Commonwealth Equity Services’s PDS Biotechnology PDSB Stock Holding History

Commonwealth Equity Services’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.9K	Buy	92,997 +2,200	+2%	+$2.33K	﹤0.01%	4271
2026 Q1	$54.9K	Sell	90,797 -106,000	-54%	-$79.7K	﹤0.01%	4195
2025 Q4	$151K	Buy	196,797 +106,300	+117%	+$95.9K	﹤0.01%	4040
2025 Q3	$91K	Sell	90,497 -175	-0.2%	-$206	﹤0.01%	4102
2025 Q2	$121K	Sell	90,672 -1,358	-1%	-$1.84K	﹤0.01%	4031
2025 Q1	$110K	Buy	92,030 +14,305	+18%	+$20.3K	﹤0.01%	3975
2024 Q4	$127K	Sell	77,725 -672	-0.9%	-$1.78K	﹤0.01%	3865
2024 Q3	$299K	Sell	78,397 -530	-0.7%	-$1.77K	﹤0.01%	3356
2024 Q2	$231K	Sell	78,927 -930	-1%	-$2.98K	﹤0.01%	3532
2024 Q1	$316K	Buy	79,857 +2,850	+4%	+$14.7K	﹤0.01%	3225
2023 Q4	$383K	Buy	77,007 +10,429	+16%	+$51.8K	﹤0.01%	2957
2023 Q3	$336K	Buy	66,578 +3,025	+5%	+$16.6K	﹤0.01%	2925
2023 Q2	$320K	Buy	63,553 +2,503	+4%	+$16.4K	﹤0.01%	2996
2023 Q1	$375K	Buy	61,050 +50	+0.1%	+$409	﹤0.01%	2788
2022 Q4	$805K	Buy	61,000 +100	+0.2%	+$705	﹤0.01%	2106
2022 Q3	$180K	Buy	60,900 +2,440	+4%	+$10.4K	﹤0.01%	3219
2022 Q2	$213K	Buy	58,460 +5,085	+10%	+$24.2K	﹤0.01%	3141
2022 Q1	$330K	Buy	53,375 +4,300	+9%	+$26.7K	﹤0.01%	2891
2021 Q4	$397K	Buy	49,075 +32,955	+204%	+$355K	﹤0.01%	2725
2021 Q3	$240K	Buy	+16,120	New	+$201K	﹤0.01%	3117

Other funds holding PDSB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Commonwealth Equity Services's PDSB Position: Q2 2026 in Review

Commonwealth Equity Services increased its PDS Biotechnology (PDSB) stake by 2.4% in Q2 2026, buying an estimated $2.33K and bringing the position to 92,997 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4271.

Commonwealth Equity Services first reported a position in PDSB in Q3 2021 and has held it in 20 quarters since. The position peaked at $805K in Q4 2022. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

Commonwealth Equity Services held 92,997 shares of PDS Biotechnology worth $81.9K as of Q2 2026.
Commonwealth Equity Services bought 2,200 PDS Biotechnology shares in Q2 2026, an estimated $2.33K.
PDS Biotechnology made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4271 holding.
Commonwealth Equity Services first reported a position in PDS Biotechnology in Q3 2021 and has held it in 20 quarters since.
Commonwealth Equity Services's PDS Biotechnology position peaked at $805K in Q4 2022.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.